Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

Completed

Conditions studied: Acute ST Segment Elevation Myocardial Infarction

In brief

The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).

Key facts

Study ID

NCT05949515

Run by

Cardiovascular Research Foundation, New York

People needed

403

Starts

2023-07-31

Expected to finish

2024-03-31

Last updated by the study team

2024-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Data from all patients who received SSO2 treatment and have completed a minimum of 3 months follow up will be collected at each participating center; there are no other exclusion criteria aside from date of treatment.

Where it is running

• Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute — Miami, Florida, United States
• NCH Healthcare System — Naples, Florida, United States
• Oakwood Healthcare, Inc — Dearborn, Michigan, United States
• Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States
• Northwell Health, Inc — Great Neck, New York, United States
• OhioHealth Research Institute — Columbus, Ohio, United States
• Avita Health — Galion, Ohio, United States
• St. Mary's Medical Center — Huntington, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.